Why the study?
Does MR-proANP and MR-proADM testing improve the diagnostic and prognostic evaluation in patients with acute dyspnoea?
Does MR-proANP and MR-proADM testing improve the diagnostic and prognostic evaluation in patients with acute dyspnoea?
MR-proANP and MR-proADM testing provides diagnostic accuracy for ADHF and independent prognostic value up to 4 years in patients presenting with acute dyspnea.
MR-proANP may aid ADHF diagnosis in acute dyspnea; leaves open whether MR-proANP/MR-proADM testing improves outcomes.
Among patients with acute dyspnoea, MR-proANP is accurate for diagnosis of ADHF, while both MR-proANP and MR-proADM are independently prognostic to 4 years of the follow-up.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: